BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32026433)

  • 21. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Postoperative Gamma Knife Radiosurgery to the Tumor Bed After Resection of Brain Metastases.
    Choi JW; Im YS; Kong DS; Seol HJ; Nam DH; Lee JI
    World Neurosurg; 2015 Dec; 84(6):1752-7. PubMed ID: 26211856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Barfod BE; Kasuya H; Urakawa Y
    J Neurosurg; 2013 Jun; 118(6):1258-68. PubMed ID: 23600938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of treatment results between 3- and 2-stage Gamma Knife radiosurgery for large brain metastases: a retrospective multi-institutional study.
    Serizawa T; Higuchi Y; Yamamoto M; Matsunaga S; Nagano O; Sato Y; Aoyagi K; Yomo S; Koiso T; Hasegawa T; Nakazaki K; Moriki A; Kondoh T; Nagatomo Y; Okamoto H; Kohda Y; Kawai H; Shidoh S; Shibazaki T; Onoue S; Kenai H; Inoue A; Mori H
    J Neurosurg; 2018 Sep; 131(1):227-237. PubMed ID: 30192195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.
    Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM
    Cancer Med; 2017 Sep; 6(9):2076-2086. PubMed ID: 28776956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
    Halasz LM; Uno H; Hughes M; D'Amico T; Dexter EU; Edge SB; Hayman JA; Niland JC; Otterson GA; Pisters KM; Theriault R; Weeks JC; Punglia RS
    Cancer; 2016 Jul; 122(13):2091-100. PubMed ID: 27088755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article.
    Salvetti DJ; Nagaraja TG; McNeill IT; Xu Z; Sheehan J
    J Neurosurg; 2013 Jun; 118(6):1250-7. PubMed ID: 23540265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-Session versus Multisession Gamma Knife Radiosurgery for Large Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis.
    Park K; Kim JW; Chung HT; Paek SH; Kim DG
    Stereotact Funct Neurosurg; 2019; 97(2):94-100. PubMed ID: 31117101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications after stereotactic radiosurgery for brain metastases: Incidences, correlating factors, treatments and outcomes.
    Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H; Barfod BE
    Radiother Oncol; 2018 Nov; 129(2):364-369. PubMed ID: 30293644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volumetric response to radiosurgery for brain metastasis varies by cell of origin.
    Iyer A; Harrison G; Kano H; Weiner GM; Luther N; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
    J Neurosurg; 2014 Sep; 121(3):564-9. PubMed ID: 24878286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
    Zimmerman AL; Murphy ES; Suh JH; Vogelbaum MA; Barnett GH; Angelov L; Ahluwalia M; Reddy CA; Chao ST
    Technol Cancer Res Treat; 2016 Feb; 15(1):186-95. PubMed ID: 25633136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.